Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02149290 · ClinicalTrials.gov registry record
LifeVest Trends Validation Protocol
A clinical trial, sponsored by Zoll Medical Corporation.
- Completed
- Registry status
- 198
- Enrollment target
NCT02149290: Completed study, sponsored by Zoll Medical Corporation.
NCT02149290 is a clinical trial that has completed, run by Zoll Medical Corporation. The registered enrollment target is 198 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02149290 has completed, sponsored by Zoll Medical Corporation.
- COMPLETED
- Registry status
- 198 participants
- Enrollment target
Study Summary
This study will evaluate the accuracy of data on body position, daily activity, heart rate, 6-minute walk test, and a health survey collected by the wearable cardioverter defibrillator (WCD).
Primary Outcome
Relationship of the step count and distance measure of the LifeVest walk test in heart failure patients as compared to distance measure of medically supervised 6-minute walk test. Accuracy of activities, and body position in patients with heart failure as compared to patient diaries of activity and sleeping position.
Interventions
- DEVICE Trends-equipped LifeVest 4000
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2014-02 |
| Est. Completion | 2017-12 |
What the finished NCT02149290 record still lists
NCT02149290 is an observational study that tracks outcomes without assigning an intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Trends-equipped LifeVest 4000 is the first listed.
NCT02149290 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02149290 about?
NCT02149290 is a clinical study titled "LifeVest Trends Validation Protocol". This study will evaluate the accuracy of data on body position, daily activity, heart rate, 6-minute walk test, and a health survey collected by the wearable cardioverter defibrillator (WCD).
What is the current status of trial NCT02149290?
This trial is currently completed. The enrollment target is 198 participants. The study started on 2014-02. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02149290?
The interventions under investigation include: Trends-equipped LifeVest 4000 (DEVICE).
Who is sponsoring clinical trial NCT02149290?
This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia